Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms

Hepatitis B remains one of the major global health problems more than 40 years after the identification of human hepatitis B virus (HBV) as the causative agent. A critical turning point in combating this virus was the development of a preventative vaccine composed of the HBV surface (envelope) prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Joan Kha-Tu, Jeevan-Raj, Beena, Netter, Hans-Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077199/
https://www.ncbi.nlm.nih.gov/pubmed/31973017
http://dx.doi.org/10.3390/v12020126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077199/
https://www.ncbi.nlm.nih.gov/pubmed/31973017
http://dx.doi.org/10.3390/v12020126

Ejemplares similares